564 related articles for article (PubMed ID: 26951159)
1. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.
Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H
J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159
[TBL] [Abstract][Full Text] [Related]
2. Case report: Neuromuscular block induced by rocuronium following sugammadex administration.
Askin T; Unver S; Oguz D; Kutay K
J Clin Anesth; 2017 Feb; 37():166-167. PubMed ID: 28235515
[TBL] [Abstract][Full Text] [Related]
3. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
[TBL] [Abstract][Full Text] [Related]
5. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
7. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
11. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.
Groudine SB; Soto R; Lien C; Drover D; Roberts K
Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
de Boer HD; Driessen JJ; van Egmond J; Booij LH
Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
[No Abstract] [Full Text] [Related]
13. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone on sugammadex reversal times of rocuronium: a systematic review protocol.
Held CR; Sullivan MD
JBI Database System Rev Implement Rep; 2017 Jun; 15(6):1543-1551. PubMed ID: 28628514
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block.
Buonanno P; Laiola A; Palumbo C; Spinelli G; Servillo G; Di Minno RM; Cafiero T; Di Iorio C
Anesth Analg; 2016 Jun; 122(6):1826-30. PubMed ID: 27028777
[TBL] [Abstract][Full Text] [Related]
16. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
[TBL] [Abstract][Full Text] [Related]
18. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.
Kadoi Y; Hoshi H; Nishida A; Saito S
J Anesth; 2011 Dec; 25(6):855-9. PubMed ID: 21947754
[TBL] [Abstract][Full Text] [Related]
19. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
20. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
